Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Noxopharm granted first US patent for Sofra immune-modulation platform
October 22, 2025 - - Latest News -
4DMedical secures Stanford as first commercial site and expands AstraZeneca partnership in Brazil
October 22, 2025 - - Latest News -
ImpediMed accelerates growth strategy on strong results and expanding market reach
October 22, 2025 - -
IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus
October 21, 2025 - - Latest News -
Clarity Pharmaceuticals’ copper theranostics platform delivers superior prostate cancer imaging results
October 21, 2025 - - Latest News -
PYC Therapeutics launches global repeat-dose trial for potential first-in-class ADOA treatment
October 21, 2025 - - Latest News -
Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome
October 20, 2025 - - Latest News